Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Waystar Holding
WAY
Waystar Holding
Advanced AI And Cloud RCM Will Transform Digital Healthcare
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 13 Analysts
Published
08 Jun 25
Updated
24 Jul 25
1
Set Fair Value
0
votes
Share
AnalystConsensusTarget
's Fair Value
US$48.21
29.7% undervalued
intrinsic discount
24 Jul
US$33.91
Loading
1Y
42.2%
7D
-8.3%
Author's Valuation
US$48.2
29.7% undervalued
intrinsic discount
AnalystConsensusTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystConsensusTarget Fair Value
US$48.2
29.7% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-74m
1b
2021
2022
2023
2024
2025
2026
2027
2028
Revenue US$1.3b
Earnings US$228.7m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
8.63%
Healthtech revenue growth rate
4.19%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.30%
Calculation
US$228.73m
Earnings '28
x
51.35x
PE Ratio '28
=
US$11.74b
Market Cap '28
US$11.74b
Market Cap '28
/
193.59m
No. shares '28
=
US$60.67
Share Price '28
US$60.67
Share Price '28
Discounted to 2025 @ 7.88% p.a.
=
US$48.32
Fair Value '25